Sound waves target brain cancer in new treatment trial
NCT ID NCT07274787
Summary
This study is testing whether a device called the NaviFUS system, which uses focused ultrasound, is safe and might help when used with the standard drug bevacizumab for adults with glioblastoma (GBM) that has come back. The ultrasound is meant to temporarily open the blood-brain barrier to potentially help the drug reach the tumor better. The main goal is to check for safety, but researchers will also look at whether the treatment helps slow tumor growth and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GBM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45219, United States
Conditions
Explore the condition pages connected to this study.